Skip to main content
Contact Us
Subscribe
E-Edition
65°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Major Depressive Disorder
Recent news which mentions Major Depressive Disorder
LSD Microdosing For Depression? This Clinical Study Reveals Promising Results
February 26, 2024
Tickers
NEWS
Tags
LSD Microdosing
Market News
major depressive disorder
From
Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
Tags
News
CYBN
Psychedelic/Assisted Therapies
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
Penny Stocks
Market News
major depressive disorder
From
Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
September 26, 2023
Tickers
CYBN
DMTTF
Tags
CYBN
Psychedelic/Assisted Therapies
Global
From
Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
Psychedelic/Assisted Therapies
Benzinga
FDA
From
Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
Tags
major depressive disorder
Market News
Cannabis
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
Penny Stocks
Markets
DMT Entities
From
Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
April 17, 2023
Tickers
MNMD
Tags
Markets
University Hospital Basel
Health Care
From
Benzinga
Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder
April 14, 2023
Tickers
CMPS
Tags
Small Cap
Cannabis
Sunstone Therapies
From
Benzinga
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
April 04, 2023
Tickers
DMTTF
Tags
Markets
DMT Entities
major depressive disorder
From
Benzinga
FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder
March 23, 2023
Tickers
HUGE
Tags
Psychoactive Substances
Cannabis
Psychedelics
From
Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Tickers
DMTTF
Tags
News
Short/Acting Psychedelics
Benzinga
From
Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
January 31, 2023
Tickers
CMND
Tags
major depressive disorder
Market News
Ketamine Treatment
From
Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Tickers
DMTTF
Tags
Penny Stocks
DMT Entities
Markets
From
Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
December 22, 2022
Tickers
DMTTF
Tags
Psychedelic/Assisted Therapies
Benzinga
News
From
Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Tickers
DMTTF
Tags
News
DMT/Assisted Therapy
Benzinga
From
Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
December 16, 2022
Tickers
EHVVF
Tags
Penny Stocks
Market News
major depressive disorder
From
Benzinga
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Tickers
RLMD
Tags
Movers
Benzinga
Briefs
From
Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers
MSSTF
Tags
MSSTF
Markets
psilocybin therapy
From
Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
Tags
Psilocybin
Success Stories
CYB003
From
Benzinga
New Zealand Government Grants $650K For LSD Microdosing Trials
July 25, 2022
Tickers
BLRZF
Tags
Benzinga
BLRZF
News
From
Benzinga
How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps
April 29, 2022
Tags
Market News
major depressive disorder
ADHD
From
Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
March 04, 2022
Tags
psychedelics
psilocybin therapy
Markets
From
Benzinga
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
December 01, 2021
Tickers
BIIB
SAGE
Tags
Phase 3 Trial
General
Briefs
From
Benzinga
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
October 29, 2021
Tickers
ABBV
Tags
Benzinga
Movers
General
From
Benzinga
B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock
October 21, 2021
Tickers
SAGE
SEEL
Tags
Health Care
General
Briefs
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.